(Q37078397)

18 August 2017

title

Invasive aspergillosis in a paediatric haematology department: a 15-year review (English)

1 reference

18 August 2017

0 references

invasive aspergillosis

1 reference

6

Claire Galambrun

1 reference

18 August 2017

4

Corinne Pondarré

1 reference

18 August 2017

Nicolas Crassard

1

1 reference

18 August 2017

Hélène Hadden

2

1 reference

18 August 2017

Marie-Antoinette Piens

3

1 reference

18 August 2017

Richard Hadden

5

1 reference

18 August 2017

Jean-Pierre Pracros

7

1 reference

18 August 2017

Gérard Souillet

8

1 reference

18 August 2017

Thierry Basset

9

1 reference

18 August 2017

Jean-Claude Berthier

10

1 reference

18 August 2017

Noel Philippe

11

1 reference

18 August 2017

Yves Bertrand

12

1 reference

18 August 2017

publication date

1 March 2008

1 reference

18 August 2017

1 reference

18 August 2017

volume

51

1 reference

18 August 2017

issue

2

1 reference

18 August 2017

page(s)

109-116

1 reference

Efficacy and safety of amphotericin B lipid complex in 548 children and adolescents with invasive fungal infections

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2007.01449.X

Invasive fungal infections in pediatric oncology patients: 11-year experience at a single institution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2007.01449.X

Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2007.01449.X

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2007.01449.X

Aspergillosis in children with cancer: A 34-year experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2007.01449.X

The value of bronchoalveolar lavage and bronchial washings in the diagnosis of invasive pulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2007.01449.X

Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2007.01449.X

Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2007.01449.X

Voriconazole for invasive aspergillosis in oncohematological patients: a single-center pediatric experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2007.01449.X

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2007.01449.X

New antifungal drugs and new clinical trials: interpreting results may be difficult

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2007.01449.X

Aspergillosis case-fatality rate: systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2007.01449.X

Epidemiology, outcomes, and costs of invasive aspergillosis in immunocompromised children in the United States, 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2007.01449.X

Five-year-survey of invasive aspergillosis in a paediatric cancer centre. Epidemiology, management and long-term survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2007.01449.X

Therapeutic outcome in invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2007.01449.X

10.1111/J.1439-0507.2007.01449.X

21 January 2018

Identifiers

DOI

1 reference

18 August 2017

1 reference